1. Home
  2. EEIQ vs LYRA Comparison

EEIQ vs LYRA Comparison

Compare EEIQ & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$0.26

Market Cap

5.2M

Sector

Real Estate

ML Signal

HOLD

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

HOLD

Current Price

$2.05

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
LYRA
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
EEIQ
LYRA
Price
$0.26
$2.05
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
224.0K
126.1K
Earning Date
01-30-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,358,301.00
$600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.90
P/E Ratio
N/A
N/A
Revenue Growth
44.99
N/A
52 Week Low
$0.20
$1.63
52 Week High
$1.74
$37.50

Technical Indicators

Market Signals
Indicator
EEIQ
LYRA
Relative Strength Index (RSI) 39.91 31.94
Support Level $0.28 $1.63
Resistance Level $0.29 $2.58
Average True Range (ATR) 0.03 0.29
MACD -0.00 -0.05
Stochastic Oscillator 15.92 16.45

Price Performance

Historical Comparison
EEIQ
LYRA

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: